Crbntm2.1Ble
Targeted Allele Detail
|
Symbol: |
Crbntm2.1Ble |
Name: |
cereblon; targeted mutation 2.1, Benjamin L Ebert |
MGI ID: |
MGI:7312145 |
Synonyms: |
CrbnV380E/I391V |
Gene: |
Crbn Location: Chr6:106757162-106777038 bp, - strand Genetic Position: Chr6, 49.24 cM, cytoband E2
|
Alliance: |
Crbntm2.1Ble page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:326489
|
Parent Cell Line: |
iTL BF1 (ES Cell)
|
Strain of Origin: |
C57BL/6NTac
|
|
Allele Type: |
|
Targeted (Humanized sequence) |
Mutation: |
|
Nucleotide substitutions
|
|
|
Mutation details: V380E (GTG to GAG; exon 10) and I391V (ATT to GTG; exon 11) mutations were introduced to the gene via homologous recombination. A loxP/FRT-flanked neomycin cassette placed in intron 9 was excised in the ES cells expressing FLP recombinase, leaving one set of loxP/FRT sites. The humanized mutations create sensitivity to thalidomide analogues in the mouse.
(J:326489)
|
|
|
|
Original: |
J:326489 Sellar RS, et al., Degradation of GSPT1 causes TP53-independent cell death in leukemia whilst sparing normal hematopoietic stem cells. J Clin Invest. 2022 Jun 28;:e153514 |
All: |
1 reference(s) |
|